During the past decade, St. Luke's Regional Medical Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 195 clinical trials were completed, i.e. on average, 6500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 48 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Luke's Regional Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 99 trials, followed by "National Cancer Institute (NCI)" with 87 trials sponsored, "Eastern Cooperative Oncology Group" with 35 trials sponsored, "SWOG Cancer Research Network" with 33 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 33 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 205 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "Eastern Cooperative Oncology Group" with 12 trials as a collaborator and "SWOG Cancer Research Network" with 11 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Regional Medical Center" are "Breast Cancer" (45 trials), "Lung Cancer" (25 trials), "Lymphoma" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (19 trials) and "Leukemia" (14 trials). Many other conditions were trialed in "St. Luke's Regional Medical Center" in a lesser frequency.

Most popular intervention types in "St. Luke's Regional Medical Center" are "Drug" (248 trials), "Other" (131 trials), "Biological" (113 trials), "Radiation" (46 trials) and "Procedure" (32 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (61 trials), "placebo" (41 trials), "Quality-of-Life Assessment" (26 trials), "Bevacizumab" (24 trials) and "Paclitaxel" (24 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Regional Medical Center" are 237 trials for "All" genders, 48 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "St. Luke's Regional Medical Center". undefined are not yet recruiting, 1 are recruiting, 60 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 200 completed trials in St. Luke's Regional Medical Center, undefined suspended trials, and 32 terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Regional Medical Center, 17 "Phase 1" clinical trials were conducted, 140 "Phase 2" clinical trials and 131 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".